| Type | Cause | Key Features |
|---|---|---|
| Primary spontaneous (PSP) | Rupture of apical bleb/bulla in otherwise healthy lung | Tall, thin, young male, smoker. Usually small. Low recurrence after first episode (~30%), high after second (~50%). |
| Secondary spontaneous (SSP) | Underlying lung disease (COPD, CF, Pneumocystis, ILD, LAM) | More dangerous -limited pulmonary reserve. Even small PTX can cause significant compromise. Lower threshold for intervention. |
| Traumatic | Blunt/penetrating chest trauma, rib fractures | Chest tube. Evaluate for hemothorax (check pleural Hct). |
| Iatrogenic | Central line (subclavian > IJ), thoracentesis, lung biopsy, positive pressure ventilation | Post-procedure CXR. Small iatrogenic PTX in stable patient โ may observe. |
| Tension | One-way valve effect โ progressive air trapping โ mediastinal shift โ โ venous return โ hemodynamic collapse | CLINICAL DIAGNOSIS: hypotension + JVD + absent breath sounds + tracheal deviation away. Needle decompression BEFORE imaging. 14โ16G needle, 2nd ICS, midclavicular line (or 5th ICS, anterior axillary line). |
| Scenario | Management |
|---|---|
| Small PSP (< 2 cm at apex), stable | Observation + high-flow Oโ (accelerates reabsorption 4ร). Repeat CXR in 4โ6h. Discharge if stable and improving. |
| Large PSP (โฅ 2 cm) or symptomatic | Needle aspiration (14โ16G, 2nd ICS) โ recheck CXR. If re-expands โ observe. If fails โ chest tube. BTS Guidelines, 2023: aspiration first-line for PSP. |
| SSP -any size | Chest tube (14โ28 Fr) connected to water seal or low suction (โ20 cmHโO). These patients have no reserve. Do NOT just observe SSP. |
| Tension PTX | Immediate needle decompression โ chest tube. Do not wait for CXR. |
| Recurrent PSP (โฅ 2 episodes ipsilateral) | VATS with pleurodesis (mechanical or chemical). Recurrence after first: ~30%. After VATS: < 5%. |
Patient: 24M, tall and thin (6'3", 155 lb), sudden right-sided pleuritic chest pain while at rest. SpOโ 96%. CXR: 25% right pneumothorax. Hemodynamically stable. No underlying lung disease.
Key findings: Primary spontaneous PTX, rupture of apical subpleural blebs in a classic demographic (tall, thin, young male, smoker). No underlying lung disease. Moderate size (> 2 cm at hilum).
Management:
Teaching point: Needle aspiration is first-line for primary spontaneous PTX, it's as effective as chest tube with less pain, shorter hospital stay, and fewer complications. Large-bore chest tubes are overused for simple pneumothoraces.
Patient: 68M with severe COPD (FEV1 28%). Acute worsening dyspnea. SpOโ 82% on 2L NC (baseline 90%). CXR: left pneumothorax ~20%. HR 112, BP 108/68.
Key findings: Secondary spontaneous PTX in COPD, even a small PTX is dangerous because of minimal pulmonary reserve. BTS guidelines: ALL secondary PTX > 1 cm or symptomatic need intervention (lower threshold than primary).
Management:
Teaching point: Secondary PTX is always more dangerous than primary, the diseased lung cannot compensate. Threshold for intervention is lower (any symptomatic PTX), and these patients require admission, not outpatient management.
Patient: 28M with third right-sided spontaneous PTX in 2 years. Current episode: 35% PTX, managed with chest tube (resolved in 48h). Previous 2 episodes also required chest tubes.
Key findings: Recurrent ipsilateral PTX, after first episode, recurrence risk is ~30%. After second episode, ~50%. After third, > 80%. Definitive prevention is indicated.
Management:
Teaching point: Pleurodesis after second ipsilateral PTX is standard of care. VATS blebectomy + pleurodesis reduces recurrence from > 50% to < 5%. Pilots and scuba divers should have pleurodesis after FIRST episode due to occupational hazard.
See the Overview and Management tabs for the pneumothorax workup algorithm (CXR upright expiratory, CT chest for occult/loculated, CTA if PE suspected, ABG for oxygenation).
Medication details (high-flow Oโ to accelerate air reabsorption, analgesia for chest tube, pleurodesis agents like talc/doxycycline for recurrent pneumothorax) are in the Management tab with evidence-based dosing.